投资工具 / 美股
Bio-Techne · TECH
数据仅供参考,不构成投资建议。
投资工具 / 美股
数据仅供参考,不构成投资建议。
| 季度 | 截止日 | 申报日 | 营收 | 营收同比 g | Δg | 推导方式 |
|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | 2026-11-12 | $299.71M | +4.6% | +3.3pp | 3M |
| 2026Q2 | 2026-06-30 | 2026-08-24 | $321.19M | +1.3% | +2.8pp | FY-9M |
| 2026Q1 | 2026-03-31 | 2026-05-06 | $311.42M | −1.5% | −1.1pp | 3M |
| 2025Q4 | 2025-12-31 | 2026-02-04 | $295.88M | −0.4% | +0.6pp | 3M |
| 2025Q3 | 2025-09-30 | 2026-11-12 | $286.56M | −1.0% | −4.6pp | 3M |
| 2025Q2 | 2025-06-30 | 2026-08-24 | $316.96M | +3.5% | −0.7pp | FY-9M |
| 2025Q1 | 2025-03-31 | 2026-05-06 | $316.18M | +4.2% | −4.8pp | 3M |
| 2024Q4 | 2024-12-31 | 2026-02-04 | $297.03M | +9.0% | +4.4pp | 3M |
口径:单季同比;Δg = 本季 g − 上季 g;按财季映射日历季度;申报日可见。† 不连续点(上年同季营收 ≤0 或 Δg 幅度超过 50pp)。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| 季度 | 截止日 | 毛利 | 销货成本 | 毛利率 | 环比 | 同比 | Δ² |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | $196.62M | $103.09M | 65.6% | −21bp | −4bp | −313bp |
| 2026Q2 | 2026-06-30 | $211.39M | $109.8M | 65.8% | −107bp | +309bp | +407bp |
| 季度 | 截止日 | 合同负债 | CL g | RPO | RPO g | 账单额 | 账单额 g | RPO 覆盖 |
|---|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | $34.7M | +6.1% | 无数据 | 无数据 | $296.01M | +4.2% | 无数据 |
| 2026Q2 | 2026-06-30 | $38.4M | +8.8% |
| 季度 | 截止日 | OCF TTM | OCF g | CapEx TTM | CapEx g | FCF TTM | CapEx 密度 | SBC/FCF | SBC/Rev |
|---|---|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | $337.6M | +34.4% | $29.4M | +8.1% | $308.2M | 2.4% | 14.0% | 3.5% |
| 2026Q2 | 2026-06-30 | $292.07M |
| 季度 | 截止日 | 存货 | 存货 g | 营收 g | 剪刀差 | DIO | DIO 同比 |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | $197.67M | −2.7% | +4.6% | −7.3pp | 175.0 | −13.4 |
| 2026Q2 | 2026-06-30 | $195.74M | +3.3% | +1.3% | +2.0pp | 162.7 |
| 交易日 | 申报日 | 申报人 | 头衔 | 代码 | 股数 | 价格 | 金额 | 10b5-1 |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | 2026-05-12 | Herr Amy E. | — | S | 6,636 | $48.28 | $320.39K | |
| 2026-02-17 |
口径:修正广度 =(近 30 日上调 − 下调)/(上调 + 下调),样本 < 3 不出;只展示衍生指标,不展示一致预期原值。 · 数据截至 2026-11-16 · 来源:Yahoo Finance / Nasdaq
未覆盖(期权覆盖为 S&P 500 期权持仓前 100 名每日、其余每周轮换)
暂无警报
口径:本股的警报事件历史(含基线);事件保留 90 天。
| 2026Q1 | 2026-03-31 | $208.29M | $103.13M | 66.9% | +224bp | −97bp | −35bp |
| 2025Q4 | 2025-12-31 | $191.28M | $104.6M | 64.6% | −100bp | −63bp | −305bp |
| 2025Q3 | 2025-09-30 | $188.11M | $98.44M | 65.6% | +292bp | +242bp | +613bp |
| 2025Q2 | 2025-06-30 | $198.81M | $118.15M | 62.7% | −513bp | −371bp | −414bp |
| 2025Q1 | 2025-03-31 | $214.56M | $101.63M | 67.9% | +258bp | +43bp | −7bp |
| 2024Q4 | 2024-12-31 | $193.89M | $103.15M | 65.3% | +205bp | +50bp | +414bp |
口径:GM = 毛利/营收;毛利缺失时用 营收−销货成本 推导;环比/同比为基点。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| 无数据 |
| $318.89M |
| +0.7% |
| 无数据 |
| 2026Q1 | 2026-03-31 | $40.7M | +14.3% | 无数据 | 无数据 | $319.12M | −0.7% | 无数据 |
| 2025Q4 | 2025-12-31 | $33M | +8.6% | 无数据 | 无数据 | $296.18M | −0.7% | 无数据 |
| 2025Q3 | 2025-09-30 | $32.7M | +12.0% | 无数据 | 无数据 | $283.96M | −1.6% | 无数据 |
| 2025Q2 | 2025-06-30 | $35.3M | +16.9% | 无数据 | 无数据 | $316.66M | +4.1% | 无数据 |
| 2025Q1 | 2025-03-31 | $35.6M | +11.3% | 无数据 | 无数据 | $321.38M | +5.3% | 无数据 |
| 2024Q4 | 2024-12-31 | $30.4M | +1.0% | 无数据 | 无数据 | $298.23M | +7.7% | 无数据 |
口径:g = 同比;账单额 = 营收 + Δ合同负债(同口径);RPO 覆盖 = RPO / TTM 营收。跨口径(总额/仅流动)不比较。 合同负债口径: 总额 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| +1.6% |
| $28.85M |
| −7.0% |
| $263.22M |
| 2.4% |
| 15.7% |
| 3.4% |
| 2026Q1 | 2026-03-31 | $294.86M | +11.3% | $25.26M | −42.7% | $269.6M | 2.1% | 15.1% | 3.4% |
| 2025Q4 | 2025-12-31 | $249.32M | −18.2% | $26.3M | −47.8% | $223.02M | 2.2% | 18.6% | 3.4% |
| 2025Q3 | 2025-09-30 | $251.25M | −17.2% | $27.2M | −53.5% | $224.06M | 2.2% | 18.9% | 3.5% |
| 2025Q2 | 2025-06-30 | $287.56M | −3.8% | $31.01M | −50.7% | $256.55M | 2.5% | 15.9% | 3.3% |
| 2025Q1 | 2025-03-31 | $264.85M | −13.7% | $44.1M | −20.9% | $220.76M | 3.6% | 19.6% | 3.6% |
| 2024Q4 | 2024-12-31 | $304.72M | +10.2% | $50.41M | −1.2% | $254.3M | 4.2% | 15.8% | 3.4% |
口径:TTM = 近四个离散单季之和;FCF = OCF − CapEx;CapEx 密度 = CapEx/营收 TTM;FCF≤0 时 SBC/FCF 不计算。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| +16.4 |
| 2026Q1 | 2026-03-31 | $201.18M | +5.3% | −1.5% | +6.8pp | 178.0 | +6.4 |
| 2025Q4 | 2025-12-31 | $205.45M | +9.1% | −0.4% | +9.5pp | 179.2 | +12.6 |
| 2025Q3 | 2025-09-30 | $203.19M | +9.8% | −1.0% | +10.8pp | 188.3 | +29.7 |
| 2025Q2 | 2025-06-30 | $189.45M | +5.4% | +3.5% | +1.9pp | 146.3 | −13.3 |
| 2025Q1 | 2025-03-31 | $191.08M | +6.5% | +4.2% | +2.3pp | 171.6 | +5.8 |
| 2024Q4 | 2024-12-31 | $188.37M | +4.2% | +9.0% | −4.8pp | 166.6 | −5.2 |
口径:剪刀差 = 存货同比 − 营收同比(pp,正值=存货增速快于营收);DIO = 存货/销货成本 × 91.25 天。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| 2026-02-19 |
| Herr Amy E. |
| — |
| S |
| 1,976 |
| $59.11 |
| $116.8K |
| 2025-08-25 | 2025-08-27 | Nusse Roeland | — | S | 17,040 | $56.36 | $960.37K |
| 2025-08-25 | 2025-08-27 | BAUMGARTNER ROBERT V | — | S | 17,040 | $56.21 | $957.82K |
| 2025-06-09 | 2025-06-11 | Herr Amy E. | — | S | 1,280 | $49.77 | $63.71K |
| 2025-02-14 | 2025-02-18 | Herr Amy E. | — | S | 1,860 | $65.96 | $122.69K |
| 2025-01-27 | 2025-01-29 | Kelderman Kim | Chief Executive Officer | S | 1,661 | $77.95 | $129.47K |
| 2025-01-27 | 2025-01-29 | Kelderman Kim | Chief Executive Officer | S | 11,731 | $77.19 | $905.52K |
口径:Form 4/4A 公开市场买入(P)与卖出(S),申报人为董事或高管;汇总与集群为近 365 天,明细为最近 40 笔。 · 数据截至 2026-11-16 · 来源:SEC EDGAR Form 4
口径:SI 来自 FINRA(双周结算);SI% 分母 = SEC 封面总股本;借券费为 IBKR 报价(非全市场);卖空占比 = 当日卖空量/总成交量。 · 数据截至 SI 2026-10-30 · Reg SHO 2026-11-16 · 借券 2026-11-11 · 沿用上一版 · 来源:FINRA、IBKR、iBorrowDesk